BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Clin Oncol. Oct 24, 2026; 17(10): 125097
Published online Oct 24, 2026. doi: 10.5306/wjco.125097
Table 5 Clinicopathological features of signet ring carcinoma, signet ring carcinoma/poorly cohesive carcinoma-not otherwise specified, and poorly cohesive carcinoma-not otherwise specified after propensity score matching, n (%)


Before PSM
After PSM
SRC
SRC/PCC-NOS
PCC-NOS
P value
SMD
SRC
SRC/PCC-NOS
PCC-NOS
P value
SMD
n70171133565656
SexFemale37 (52.857)95 (55.556)44 (33.083)< 0.0010.30927 (48.214)29 (51.786)29 (51.786)0.9090.048
Male33 (47.143)76 (44.444)89 (66.917)29 (51.786)27 (48.214)27 (48.214)
Age< 6028 (40.000)82 (47.953)53 (39.850)0.5810.14426 (46.429)25 (44.643)25 (44.643)0.9840.094
60-7436 (51.429)74 (43.275)65 (48.872)27 (48.214)27 (48.214)26 (46.429)
≥ 756 (8.571)15 (8.772)15 (11.278)3 (5.357)4 (7.143)5 (8.929)
StageI35 (51.471)44 (26.347)25 (19.380)< 0.0010.58027 (48.214)26 (46.429)25 (44.643)0.9950.080
II12 (17.647)24 (14.371)18 (13.953)8 (14.286)8 (14.286)10 (17.857)
III19 (27.941)86 (51.497)82 (63.566)19 (33.929)20 (35.714)19 (33.929)
IV2 (2.941)13 (7.784)4 (3.101)2 (3.571)2 (3.571)2 (3.571)


Write to the Help Desk